Delivery Order SPE2DB20D2014-SPE2DB24FB36T

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $2.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NovologTM 100 unit/mL Flexpen 3mL insulin products. The $1,703.48 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 28, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
This federal contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the delivery of NovologTM 100 Unit/mL FlexPenTM 3mL, a common insulin delivery device. The $2,097.12 delivery order contract is a firm fixed-price arrangement with an ultimate completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This federal contract award is for the delivery of NovologTM 100 Unit/mL FlexPen® 3mL, a prescription insulin medication, to the Defense Logistics Agency (DLA). The $1,838.16 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 6, 2023. The contract has an ultimate completion date of April 7, 2023 and is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of NovologⓇ 100 Unit/mL FlexPenⓇ 3mL insulin products. The $1,497.96 contract has a performance period through March 15, 2024 and does not have a set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing $999,999,999.00 indefinite delivery contract with DLA to supply a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order for the provision of NovologTM 100 unit/mL FlexPen 3mL. The award, valued at $1,420.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, and has a performance period through March 26, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NovologTM 100 unit/mL FlexPen 3mL, a prescription insulin medication. The fixed-price, firm-fixed-price contract has a ceiling value of $1,327.70 and an ultimate completion date of July 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NovOlog 100 unit/mL FlexPen 3mL, a type of insulin delivery device. The $1,092.43 firm-fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NovologⓇ 100 Unit/mL FlexPenⓇ 3mL insulin pens. The $1,089.28 firm fixed-price delivery order was placed by the Defense Logistics Agency, a defense agency, and has a completion date of June 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 single-award Indefinite Delivery Contract with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,152.35 firm fixed-price delivery order is for NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The award has an ultimate completion date of December 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB36T
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is for the delivery of NovologTM 100 unit/mL FlexPen 3mL, a brand name insulin product. The $2,700.27 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00. This IDC serves as the primary contract vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.

Generated 6/17/24, 9:09 AM